List of Excipients in API amlodipine besylate and olmesartan medoxomil
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing amlodipine besylate and olmesartan medoxomil
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Cosette Pharmaceuticals Inc | AZOR | amlodipine besylate and olmesartan medoxomil | 0713-0870 | CELLULOSE, MICROCRYSTALLINE | |
| Cosette Pharmaceuticals Inc | AZOR | amlodipine besylate and olmesartan medoxomil | 0713-0870 | CROSCARMELLOSE SODIUM | |
| Cosette Pharmaceuticals Inc | AZOR | amlodipine besylate and olmesartan medoxomil | 0713-0870 | MAGNESIUM STEARATE | |
| Cosette Pharmaceuticals Inc | AZOR | amlodipine besylate and olmesartan medoxomil | 0713-0870 | POLYETHYLENE GLYCOL 3350 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing amlodipine besylate and olmesartan medoxomil
Detailed excipient profiles for amlodipine besylate and olmesartan medoxomil
Excipient focus: CELLULOSE, MICROCRYSTALLINE
amlodipine besylate and olmesartan medoxomil drug variants containing CELLULOSE, MICROCRYSTALLINE
amlodipine besylate and olmesartan medoxomil drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
amlodipine besylate and olmesartan medoxomil drug variants containing CROSCARMELLOSE SODIUM
amlodipine besylate and olmesartan medoxomil drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | amlodipine besylate and olmesartan medoxomil | 16729-392 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
amlodipine besylate and olmesartan medoxomil drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | amlodipine besylate and olmesartan medoxomil | 16729-392 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and olmesartan medoxomil drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
amlodipine besylate and olmesartan medoxomil drug variants containing MAGNESIUM STEARATE
amlodipine besylate and olmesartan medoxomil drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
amlodipine besylate and olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | amlodipine besylate and olmesartan medoxomil | 27241-083 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
amlodipine besylate and olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL 3350
amlodipine besylate and olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | amlodipine besylate and olmesartan medoxomil | 16729-392 |
| Ajanta Pharma USA Inc | amlodipine besylate and olmesartan medoxomil | 27241-083 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
amlodipine besylate and olmesartan medoxomil drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | amlodipine besylate and olmesartan medoxomil | 16729-392 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and olmesartan medoxomil drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYVINYL ALCOHOL
amlodipine besylate and olmesartan medoxomil drug variants containing POLYVINYL ALCOHOL
amlodipine besylate and olmesartan medoxomil drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
amlodipine besylate and olmesartan medoxomil drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Accord Healthcare Inc | amlodipine besylate and olmesartan medoxomil | 16729-392 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and olmesartan medoxomil drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
amlodipine besylate and olmesartan medoxomil drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | amlodipine besylate and olmesartan medoxomil | 27241-083 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and olmesartan medoxomil drug variants not containing SILICON DIOXIDE
Excipient focus: STARCH, CORN
amlodipine besylate and olmesartan medoxomil drug variants containing STARCH, CORN
amlodipine besylate and olmesartan medoxomil drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
amlodipine besylate and olmesartan medoxomil drug variants containing TALC
amlodipine besylate and olmesartan medoxomil drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
amlodipine besylate and olmesartan medoxomil drug variants containing TITANIUM DIOXIDE
amlodipine besylate and olmesartan medoxomil drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
